Symbol
Name
ID

Agl
amylo-1,6-glucosidase, 4-alpha-glucanotransferase
MGI:1924809

Phenotype annotations related to homeostasis/metabolism

Darker colors indicate more annotations

Human Phenotypes	Hyperlipidemia	Elevated circulating creatine kinase concentration	Elevated circulating hepatic transaminase concentration	Reduced muscle glycogen debrancher enzyme activity	Hypoglycemia
Disease(s) Associated with AGL
glycogen storage disease III

Mouse Phenotypes

impaired exercise endurance

increased cardiac muscle glycogen level

increased circulating bilirubin level

decreased fasting circulating glucose level

increased fasting circulating glucose level

decreased circulating glucose level

hypoglycemia

increased circulating cholesterol level

increased circulating iron level

increased circulating alanine transaminase level

increased circulating alkaline phosphatase level

increased circulating amylase level

increased circulating aspartate transaminase level

increased circulating creatine kinase level

impaired glucose tolerance

increased brain glycogen level

increased liver glycogen level

increased skeletal muscle glycogen level

increased glycogen level

Availability

Mouse Genotype

Agl^{tm1a(EUCOMM)Wtsi}/Agl^{tm1a(EUCOMM)Wtsi}

Agl^{tm1b(EUCOMM)Wtsi}/Agl^{tm1b(EUCOMM)Wtsi}

Agl^tm1Geno/Agl^tm1Geno

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/14/2024 MGI 6.23